Zyprexa Tablet, Orally Disintegrating
Product Images NDC 61269-652

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Zyprexa (NDC 61269-652). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H2-pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label (ZYPREXA 10 mg tablet, bottle of 30)

FDA Label Image

Package Label (ZYPREXA 15 mg tablet, bottle of 30)

FDA Label Image

Package Label (ZYPREXA 2.5 mg tablet, bottle of 30)

FDA Label Image

Package Label (ZYPREXA 20 mg tablet, bottle of 30, trade)

FDA Label Image

Package Label (ZYPREXA 5 mg tablet, bottle of 30)

FDA Label Image

Package Label (ZYPREXA 7.5 mg tablet, bottle of 30)

FDA Label Image

Package Label (ZYPREXA INTRAMUSCULAR 10 mg/vial)

FDA Label Image

Package Label (ZYPREXA ZYDIS 10 mg tablet, 30 sachets)

FDA Label Image

Package Label (ZYPREXA ZYDIS 15 mg tablet, 30 sachets)

FDA Label Image

Package Label (ZYPREXA ZYDIS 20 mg tablet, 30 sachets, trade)

FDA Label Image

Package Label (ZYPREXA ZYDIS 5 mg tablet, 30 sachets)

FDA Label Image

Chemical Structure (Zyprexa F001 V1)